US Stock MarketDetailed Quotes

Scinai Immunotherapeutics (SCNI)

Watchlist
  • 0.5914
  • -0.0006-0.10%
Close Apr 14 16:00 ET
2.09MMarket Cap-0.16P/E (TTM)

Scinai Immunotherapeutics (SCNI) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q2)Jun 30, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-15.43%1.66M
-15.43%1.66M
-67.85%989K
-59.67%1.96M
-59.67%1.96M
-83.78%1.03M
-59.02%3.08M
-55.31%4.83M
-65.40%4.87M
-65.40%4.87M
-Cash and cash equivalents
-15.43%1.66M
-15.43%1.66M
-67.85%989K
-59.67%1.96M
-59.67%1.96M
-83.78%1.03M
-59.02%3.08M
-55.31%4.83M
-65.40%4.87M
-65.40%4.87M
Receivables
-22.58%168K
-22.58%168K
-15.35%375K
-40.71%217K
-40.71%217K
96.49%448K
221.01%443K
142.02%288K
232.73%366K
232.73%366K
-Accounts receivable
-12.05%73K
-12.05%73K
16.81%139K
--83K
--83K
--120K
--119K
----
--0
--0
-Other receivables
-29.10%95K
-29.10%95K
-27.16%236K
-63.39%134K
-63.39%134K
43.86%328K
134.78%324K
142.02%288K
232.73%366K
232.73%366K
Prepaid assets
-5.06%75K
-5.06%75K
----
11.27%79K
11.27%79K
----
----
----
57.78%71K
57.78%71K
Restricted cash
14.50%150K
14.50%150K
2.90%142K
-6.43%131K
-6.43%131K
12.30%137K
9.52%138K
10.24%140K
0.00%140K
0.00%140K
Total current assets
-14.09%2.05M
-14.09%2.05M
-58.82%1.51M
-56.10%2.39M
-56.10%2.39M
-75.91%1.62M
-52.93%3.66M
-52.43%5.25M
-62.09%5.45M
-62.09%5.45M
Non current assets
Net PPE
-13.43%9.57M
-13.43%9.57M
-7.68%10.33M
-8.05%11.06M
-8.05%11.06M
-10.33%10.64M
-7.69%11.19M
-3.67%11.8M
-5.29%12.03M
-5.29%12.03M
-Gross PPE
-0.42%15.45M
-0.42%15.45M
-7.68%10.33M
4.58%15.51M
4.58%15.51M
-10.33%10.64M
-7.69%11.19M
-3.67%11.8M
-1.89%14.83M
-1.89%14.83M
-Accumulated depreciation
-31.87%-5.88M
-31.87%-5.88M
----
-58.69%-4.46M
-58.69%-4.46M
----
----
----
-15.99%-2.81M
-15.99%-2.81M
Total non current assets
-13.43%9.57M
-13.43%9.57M
-7.68%10.33M
-8.05%11.06M
-8.05%11.06M
-10.33%10.64M
-7.69%11.19M
-3.67%11.8M
-5.29%12.03M
-5.29%12.03M
Total assets
-13.55%11.63M
-13.55%11.63M
-20.27%11.84M
-23.03%13.45M
-23.03%13.45M
-34.02%12.26M
-25.36%14.85M
-26.79%17.05M
-35.45%17.47M
-35.45%17.47M
Liabilities
Current liabilities
Payables
8.24%407K
8.24%407K
24.08%1.62M
-29.72%376K
-29.72%376K
-11.07%1.03M
-12.45%1.31M
-28.76%1.54M
-25.28%535K
-25.28%535K
-accounts payable
8.24%407K
8.24%407K
0.15%659K
-29.72%376K
-29.72%376K
-21.25%430K
1.08%658K
-29.32%928K
-25.28%535K
-25.28%535K
-Other payable
----
----
48.31%964K
----
----
-1.97%598K
-22.89%650K
-27.90%610K
----
----
Current accrued expenses
-2.82%759K
-2.82%759K
----
-8.01%781K
-8.01%781K
----
----
----
-31.53%849K
-31.53%849K
Current debt and capital lease obligation
-22.41%329K
-22.41%329K
36.54%497K
7.07%424K
7.07%424K
-4.71%364K
-7.61%364K
-7.86%387K
3.66%396K
3.66%396K
-Current capital lease obligation
-22.41%329K
-22.41%329K
36.54%497K
7.07%424K
7.07%424K
-4.71%364K
-7.61%364K
-7.86%387K
3.66%396K
3.66%396K
Current deferred liabilities
-60.00%90K
-60.00%90K
----
--225K
--225K
----
----
----
--0
--0
Current liabilities
-12.24%1.59M
-12.24%1.59M
26.79%2.12M
1.46%1.81M
1.46%1.81M
-9.49%1.39M
-11.44%1.67M
-25.36%1.93M
-23.87%1.78M
-23.87%1.78M
Non current liabilities
Long term debt and capital lease obligation
16.61%1.94M
16.61%1.94M
-90.91%1.86M
-91.76%1.66M
-91.76%1.66M
-95.56%863K
-15.52%20.46M
-11.45%20.24M
-4.70%20.17M
-4.70%20.17M
-Long term debt
13.08%294K
13.08%294K
-98.52%293K
-98.66%260K
-98.66%260K
-98.49%280K
-14.91%19.82M
-10.71%19.51M
-3.56%19.37M
-3.56%19.37M
-Long term capital lease obligation
17.26%1.64M
17.26%1.64M
144.69%1.57M
75.91%1.4M
75.91%1.4M
-29.16%583K
-30.96%640K
-27.38%732K
-26.07%797K
-26.07%797K
Derivative product liabilities
--0
--0
0.00%3K
-96.88%3K
-96.88%3K
-99.04%3K
-99.67%3K
--0
-98.20%96K
-98.20%96K
Total non current liabilities
16.40%1.94M
16.40%1.94M
-90.90%1.86M
-91.78%1.67M
-91.78%1.67M
-95.61%866K
-18.54%20.46M
-20.69%20.24M
-23.51%20.26M
-23.51%20.26M
Total liabilities
1.50%3.52M
1.50%3.52M
-82.01%3.98M
-84.25%3.47M
-84.25%3.47M
-89.39%2.26M
-18.05%22.14M
-21.12%22.17M
-23.54%22.04M
-23.54%22.04M
Shareholders'equity
Share capital
0.00%5.63M
0.00%5.63M
--5.63M
--5.63M
--5.63M
--5.63M
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Preferred stock
0.00%5.63M
0.00%5.63M
--5.63M
--5.63M
--5.63M
--5.63M
----
----
--0
--0
Retained earnings
-7.07%-125.85M
-7.07%-125.85M
4.06%-121.67M
3.92%-117.54M
3.92%-117.54M
3.91%-115.31M
-3.01%-126.82M
-4.31%-124.49M
-5.61%-122.34M
-5.61%-122.34M
Paid-in capital
5.20%130.06M
5.20%130.06M
3.61%125.64M
3.45%123.63M
3.45%123.63M
1.99%121.43M
3.00%121.27M
4.03%121.12M
2.95%119.51M
2.95%119.51M
Gains losses not affecting retained earnings
0.00%-1.74M
0.00%-1.74M
0.00%-1.74M
0.00%-1.74M
0.00%-1.74M
0.00%-1.74M
0.00%-1.74M
7.99%-1.74M
13.30%-1.74M
13.30%-1.74M
Total stockholders'equity
-18.78%8.1M
-18.78%8.1M
207.88%7.86M
318.36%9.98M
318.36%9.98M
471.58%10M
-2.42%-7.28M
-6.36%-5.12M
-159.60%-4.57M
-159.60%-4.57M
Total equity
-18.78%8.1M
-18.78%8.1M
207.88%7.86M
318.36%9.98M
318.36%9.98M
471.58%10M
-2.42%-7.28M
-6.36%-5.12M
-159.60%-4.57M
-159.60%-4.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q2)Jun 30, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -15.43%1.66M-15.43%1.66M-67.85%989K-59.67%1.96M-59.67%1.96M-83.78%1.03M-59.02%3.08M-55.31%4.83M-65.40%4.87M-65.40%4.87M
-Cash and cash equivalents -15.43%1.66M-15.43%1.66M-67.85%989K-59.67%1.96M-59.67%1.96M-83.78%1.03M-59.02%3.08M-55.31%4.83M-65.40%4.87M-65.40%4.87M
Receivables -22.58%168K-22.58%168K-15.35%375K-40.71%217K-40.71%217K96.49%448K221.01%443K142.02%288K232.73%366K232.73%366K
-Accounts receivable -12.05%73K-12.05%73K16.81%139K--83K--83K--120K--119K------0--0
-Other receivables -29.10%95K-29.10%95K-27.16%236K-63.39%134K-63.39%134K43.86%328K134.78%324K142.02%288K232.73%366K232.73%366K
Prepaid assets -5.06%75K-5.06%75K----11.27%79K11.27%79K------------57.78%71K57.78%71K
Restricted cash 14.50%150K14.50%150K2.90%142K-6.43%131K-6.43%131K12.30%137K9.52%138K10.24%140K0.00%140K0.00%140K
Total current assets -14.09%2.05M-14.09%2.05M-58.82%1.51M-56.10%2.39M-56.10%2.39M-75.91%1.62M-52.93%3.66M-52.43%5.25M-62.09%5.45M-62.09%5.45M
Non current assets
Net PPE -13.43%9.57M-13.43%9.57M-7.68%10.33M-8.05%11.06M-8.05%11.06M-10.33%10.64M-7.69%11.19M-3.67%11.8M-5.29%12.03M-5.29%12.03M
-Gross PPE -0.42%15.45M-0.42%15.45M-7.68%10.33M4.58%15.51M4.58%15.51M-10.33%10.64M-7.69%11.19M-3.67%11.8M-1.89%14.83M-1.89%14.83M
-Accumulated depreciation -31.87%-5.88M-31.87%-5.88M-----58.69%-4.46M-58.69%-4.46M-------------15.99%-2.81M-15.99%-2.81M
Total non current assets -13.43%9.57M-13.43%9.57M-7.68%10.33M-8.05%11.06M-8.05%11.06M-10.33%10.64M-7.69%11.19M-3.67%11.8M-5.29%12.03M-5.29%12.03M
Total assets -13.55%11.63M-13.55%11.63M-20.27%11.84M-23.03%13.45M-23.03%13.45M-34.02%12.26M-25.36%14.85M-26.79%17.05M-35.45%17.47M-35.45%17.47M
Liabilities
Current liabilities
Payables 8.24%407K8.24%407K24.08%1.62M-29.72%376K-29.72%376K-11.07%1.03M-12.45%1.31M-28.76%1.54M-25.28%535K-25.28%535K
-accounts payable 8.24%407K8.24%407K0.15%659K-29.72%376K-29.72%376K-21.25%430K1.08%658K-29.32%928K-25.28%535K-25.28%535K
-Other payable --------48.31%964K---------1.97%598K-22.89%650K-27.90%610K--------
Current accrued expenses -2.82%759K-2.82%759K-----8.01%781K-8.01%781K-------------31.53%849K-31.53%849K
Current debt and capital lease obligation -22.41%329K-22.41%329K36.54%497K7.07%424K7.07%424K-4.71%364K-7.61%364K-7.86%387K3.66%396K3.66%396K
-Current capital lease obligation -22.41%329K-22.41%329K36.54%497K7.07%424K7.07%424K-4.71%364K-7.61%364K-7.86%387K3.66%396K3.66%396K
Current deferred liabilities -60.00%90K-60.00%90K------225K--225K--------------0--0
Current liabilities -12.24%1.59M-12.24%1.59M26.79%2.12M1.46%1.81M1.46%1.81M-9.49%1.39M-11.44%1.67M-25.36%1.93M-23.87%1.78M-23.87%1.78M
Non current liabilities
Long term debt and capital lease obligation 16.61%1.94M16.61%1.94M-90.91%1.86M-91.76%1.66M-91.76%1.66M-95.56%863K-15.52%20.46M-11.45%20.24M-4.70%20.17M-4.70%20.17M
-Long term debt 13.08%294K13.08%294K-98.52%293K-98.66%260K-98.66%260K-98.49%280K-14.91%19.82M-10.71%19.51M-3.56%19.37M-3.56%19.37M
-Long term capital lease obligation 17.26%1.64M17.26%1.64M144.69%1.57M75.91%1.4M75.91%1.4M-29.16%583K-30.96%640K-27.38%732K-26.07%797K-26.07%797K
Derivative product liabilities --0--00.00%3K-96.88%3K-96.88%3K-99.04%3K-99.67%3K--0-98.20%96K-98.20%96K
Total non current liabilities 16.40%1.94M16.40%1.94M-90.90%1.86M-91.78%1.67M-91.78%1.67M-95.61%866K-18.54%20.46M-20.69%20.24M-23.51%20.26M-23.51%20.26M
Total liabilities 1.50%3.52M1.50%3.52M-82.01%3.98M-84.25%3.47M-84.25%3.47M-89.39%2.26M-18.05%22.14M-21.12%22.17M-23.54%22.04M-23.54%22.04M
Shareholders'equity
Share capital 0.00%5.63M0.00%5.63M--5.63M--5.63M--5.63M--5.63M--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
-Preferred stock 0.00%5.63M0.00%5.63M--5.63M--5.63M--5.63M--5.63M----------0--0
Retained earnings -7.07%-125.85M-7.07%-125.85M4.06%-121.67M3.92%-117.54M3.92%-117.54M3.91%-115.31M-3.01%-126.82M-4.31%-124.49M-5.61%-122.34M-5.61%-122.34M
Paid-in capital 5.20%130.06M5.20%130.06M3.61%125.64M3.45%123.63M3.45%123.63M1.99%121.43M3.00%121.27M4.03%121.12M2.95%119.51M2.95%119.51M
Gains losses not affecting retained earnings 0.00%-1.74M0.00%-1.74M0.00%-1.74M0.00%-1.74M0.00%-1.74M0.00%-1.74M0.00%-1.74M7.99%-1.74M13.30%-1.74M13.30%-1.74M
Total stockholders'equity -18.78%8.1M-18.78%8.1M207.88%7.86M318.36%9.98M318.36%9.98M471.58%10M-2.42%-7.28M-6.36%-5.12M-159.60%-4.57M-159.60%-4.57M
Total equity -18.78%8.1M-18.78%8.1M207.88%7.86M318.36%9.98M318.36%9.98M471.58%10M-2.42%-7.28M-6.36%-5.12M-159.60%-4.57M-159.60%-4.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
At 22:00 Beijing time on April 13, the US Central Command officially blocked maritime traffic at Iranian ports, imposing the strictest sanct Show More